Shaolin Capital Management LLC
- SEC CIK
- 0001766806
- Latest filing
- Aug 14, 2026
SABSW holding history
SAB Biotherapeutics, Inc. in every 13F filed by Shaolin Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SABSW overviewAll 13F holders of SABSWFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −249,143−100.0% | Sold out | Holders |
| Q2 2024 | 249,143 | $11.8K | <0.1% | −43,822−15.0% | Reduced | Holders |
| Q1 2024 | 292,965 | $11.4K | <0.1% | −78,676−21.2% | Reduced | Holders |
| Q4 2023 | 371,641 | $11.2K | <0.1% | −94,076−20.2% | Reduced | Holders |
| Q3 2023 | 465,717 | $33.0K | <0.1% | +465,717 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −498,109−100.0% | Sold out | Holders |
| Q1 2023 | 498,109 | $18.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 498,109 | $23.0K | <0.1% | −164,590−24.8% | Reduced | Holders |
| Q3 2022 | 662,699 | $41.0K | <0.1% | −161,300−19.6% | Reduced | Holders |
| Q2 2022 | 823,999 | $156.0K | <0.1% | −1,000−0.1% | Reduced | Holders |
| Q1 2022 | 824,999 | $397.0K | <0.1% | −16,796−2.0% | Reduced | Holders |
| Q4 2021 | 841,795 | $1.51M | <0.1% | +841,795 | New | Holders |